11.10
price down icon0.36%   -0.04
 
loading
前日終値:
$11.14
開ける:
$11.14
24時間の取引高:
464.67K
Relative Volume:
0.46
時価総額:
$1.06B
収益:
$174.54M
当期純損益:
$6.03M
株価収益率:
138.75
EPS:
0.08
ネットキャッシュフロー:
$15.96M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
-1.94%
6か月 パフォーマンス:
+17.21%
1年 パフォーマンス:
+20.00%
1日の値動き範囲:
Value
$11.09
$11.15
1週間の範囲:
Value
$11.08
$11.20
52週間の値動き範囲:
Value
$7.83
$11.80

Enfusion Inc Stock (ENFN) Company Profile

Name
名前
Enfusion Inc
Name
セクター
Technology (774)
Name
電話
(312) 253-9800
Name
住所
125 SOUTH CLARK STREET, SUITE 750, CHICAGO
Name
職員
0
Name
Twitter
Name
次回の収益日
2024-08-06
Name
最新のSEC提出書
Name
ENFN's Discussions on Twitter

ENFN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Software - Application icon
ENFN
Enfusion Inc
11.10 1.06B 174.54M 6.03M 15.96M 0.08
Software - Application icon
SAP
Sap Se Adr
268.00 312.62B 36.97B 3.37B 4.79B 2.8498
Software - Application icon
CRM
Salesforce Inc
269.97 266.98B 37.90B 6.20B 12.43B 6.36
Software - Application icon
INTU
Intuit Inc
598.92 172.01B 17.17B 3.04B 5.63B 10.72
Software - Application icon
NOW
Servicenow Inc
797.76 170.92B 10.98B 1.43B 3.38B 6.83
Software - Application icon
ADBE
Adobe Inc
385.71 164.39B 22.04B 6.75B 9.19B 15.18

Enfusion Inc Stock (ENFN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-05-10 再開されました Morgan Stanley Overweight
2024-02-28 ダウングレード Goldman Neutral → Sell
2024-01-30 ダウングレード JP Morgan Neutral → Underweight
2023-11-07 開始されました UBS Neutral
2023-04-03 開始されました Piper Sandler Neutral
2023-03-15 開始されました JP Morgan Neutral
2023-01-04 ダウングレード BofA Securities Neutral → Underperform
2023-01-03 アップグレード Morgan Stanley Equal-Weight → Overweight
2022-10-03 ダウングレード BofA Securities Buy → Neutral
2021-11-15 開始されました BofA Securities Buy
2021-11-15 開始されました Credit Suisse Neutral
2021-11-15 開始されました Goldman Neutral
2021-11-15 開始されました Morgan Stanley Equal-Weight
2021-11-15 開始されました Piper Sandler Overweight
2021-11-15 開始されました Stifel Buy
2021-11-15 開始されました William Blair Outperform
すべてを表示

Enfusion Inc (ENFN) 最新ニュース

pulisher
Mar 27, 2025

Shareholder Rights Advocates at Levi & Korsinsky Investigate Enfusion, Inc. (ENFN) Regarding Possible Securities Fraud Violations - ACCESS Newswire

Mar 27, 2025
pulisher
Mar 26, 2025

Lost Money on Enfusion, Inc. (ENFN)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire

Mar 26, 2025
pulisher
Mar 20, 2025

MS cuts rating on Enfusion stock after Clearwater’s acquisition bid - MSN

Mar 20, 2025
pulisher
Mar 20, 2025

(ENFN) Trading Report - Stock Traders Daily

Mar 20, 2025
pulisher
Mar 09, 2025

Enfusion, Inc. Reports Strong Growth Amid Acquisition Plans - MSN

Mar 09, 2025
pulisher
Mar 09, 2025

Enfusion (ENFN) to Release Earnings on Tuesday - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Enfusion CEO Oleg Movchan sells $130,472 in stock By Investing.com - Investing.com South Africa

Mar 08, 2025
pulisher
Mar 08, 2025

Rhumbline Advisers Has $643,000 Stake in Enfusion, Inc. (NYSE:ENFN) - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

Enfusion’s chief people officer sells shares worth $35,558 - Investing.com India

Mar 08, 2025
pulisher
Mar 08, 2025

Enfusion CFO sells $52,836 in stock to cover tax obligations By Investing.com - Investing.com Canada

Mar 08, 2025
pulisher
Mar 07, 2025

Enfusion Executives Cash In: Major Stock Sales Unveiled! - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Enfusion chief accounting officer sells $6,165 in stock By Investing.com - Investing.com Canada

Mar 07, 2025
pulisher
Mar 07, 2025

Enfusion’s general counsel Matthew Campobasso sells $19,280 in stock - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Enfusion chief accounting officer sells $6,165 in stock - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Enfusion COO Neal Pawar sells $165,620 in stock - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Enfusion’s chief people officer sells shares worth $35,558 By Investing.com - Investing.com South Africa

Mar 07, 2025
pulisher
Mar 07, 2025

Enfusion Executives Sell Shares to Cover Tax Obligations - TradingView

Mar 07, 2025
pulisher
Mar 07, 2025

Enfusion’s Hold Rating: Balancing Strategic Merger Benefits with Market Uncertainties - TipRanks

Mar 07, 2025
pulisher
Mar 06, 2025

Enfusion’s CAO Makes a Noteworthy Stock Sale! - TipRanks

Mar 06, 2025
pulisher
Mar 06, 2025

Enfusion’s general counsel sells $12,410 in stock to cover taxes By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 06, 2025

Enfusion COO Neal Pawar sells $31,790 in stock - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

Enfusion Executives Unload Major Stock Holdings! - TipRanks

Mar 06, 2025
pulisher
Mar 05, 2025

Enfusion COO Neal Pawar sells $31,790 in stock By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 05, 2025

Enfusion chief accounting officer sells $2,514 in stock - Investing.com Australia

Mar 05, 2025
pulisher
Mar 05, 2025

Enfusion chief accounting officer sells $2,514 in stock By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 05, 2025

Enfusion CEO Oleg Movchan sells $32,031 in stock By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 05, 2025

Enfusion CFO Bradley Herring sells $17,600 in stock By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 05, 2025

Enfusion’s chief people officer sells shares worth $23,696 - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Enfusion CEO Oleg Movchan sells $32,031 in stock - Investing.com

Mar 05, 2025
pulisher
Mar 05, 2025

Enfusion’s chief people officer sells shares worth $23,696 By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 04, 2025

Stifel maintains Enfusion stock Hold rating, $11.25 target By Investing.com - Investing.com Canada

Mar 04, 2025
pulisher
Mar 04, 2025

Stifel maintains Enfusion stock Hold rating, $11.25 target - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Enfusion, Inc. (ENFN) Lags Q4 Earnings and Revenue Estimates - MSN

Mar 04, 2025
pulisher
Mar 04, 2025

Enfusion earnings missed by $0.03, revenue fell short of estimates - Investing.com Canada

Mar 04, 2025
pulisher
Mar 03, 2025

Enfusion Q4 Adjusted Earnings Fall, Revenue Rises -March 03, 2025 at 05:38 pm EST - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

Enfusion Announces Fourth Quarter and Full Year 2024 Results - TradingView

Mar 03, 2025
pulisher
Mar 03, 2025

Earnings Flash (ENFN) ENFUSION INC. Reports Q4 Revenue $52.9M, vs. FactSet Est of $54.3M - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

Earnings Flash (ENFN) ENFUSION INC. Reports Q4 Adjusted EPS $0.03, vs. FactSet Est of $0.06 - Marketscreener.com

Mar 03, 2025
pulisher
Mar 02, 2025

ATTENTION ENFN SHAREHOLDERS: Investors who lost money on Enfusion, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation - ACCESS Newswire

Mar 02, 2025
pulisher
Feb 27, 2025

Clearwater Analytics Awaits Enfusion Acquisition Completion - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Fintech Merger Advances: Clearwater-Enfusion Deal Passes Key Regulatory TestWhat's Next? - StockTitan

Feb 27, 2025
pulisher
Feb 27, 2025

Objective long/short (ENFN) Report - Stock Traders Daily

Feb 27, 2025

Enfusion Inc (ENFN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$289.41
price down icon 10.84%
software_application APP
$272.38
price up icon 4.08%
software_application ADP
$300.83
price down icon 1.51%
$96.68
price down icon 5.70%
$72.75
price down icon 2.82%
$385.71
price down icon 2.64%
大文字化:     |  ボリューム (24 時間):